Essential clinical instruments and therapeutic compounds optimized for the Health Sciences Authority (HSA) standards.
Singapore serves as the premier medical hub in Southeast Asia, characterized by a sophisticated regulatory framework governed by the Health Sciences Authority (HSA). As the nation moves towards the "Healthier SG" initiative, the demand for high-quality medical devices and pharmaceutical intermediates has reached an all-time high. The market is not merely looking for suppliers but for strategic partners who provide Information Gain—insights into manufacturing transparency, batch consistency, and regulatory compliance.
Currently, Singapore's MedTech sector accounts for a significant portion of the country's manufacturing output. With an aging population—the "Silver Tsunami"—there is a specialized surge in demand for respiratory treatment products, urinary catheters, and chronic disease management medications. Our service model integrates these local requirements with global manufacturing prowess, ensuring that every product, from a simple suction tube to complex API like Creatine Phosphate Sodium, meets the rigorous safety and efficacy standards required by Singapore’s private and public healthcare clusters (NUHS, SingHealth, and NHG).
Class A-D Compliant
Global MedTech Hub
Supply Chain 4.0
Logistics Lag Policy
In the post-pandemic era, procurement officers in Singapore are prioritizing Supply Chain Resilience. Our manufacturing facilities in China have transitioned into "Factory 4.0" environments. This involves the integration of AI-driven quality control, automated assembly lines for medical consumables, and real-time data tracking for pharmaceutical synthesis.
Why does this matter for the Singapore market? It means efficiency and cost-advantage without compromising on E-E-A-T principles. By utilizing IoT-enabled production, we ensure that products like our Triple Lumen Foley Catheters have a defect rate of less than 0.001%. Our "Smart Manufacturing" approach allows for rapid scaling—essential for Singapore’s emergency stockpiling requirements.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Monitoring the development of cutting-edge markets to provide high-value medical solutions.
Customized formulations for specific clinical therapeutic needs in Singapore hospitals.
Enhancing the solubility and bioavailability of APIs for better patient outcomes.
Sustainable production of high-purity nutritional ingredients and biological precursors.
The shift towards plant-based squalene in Singapore's dermo-pharmaceutical sector is accelerating.
A deep dive into the stability and procurement of Dexamethasone Sodium Phosphate API for Singapore clinics.
Eli Lilly's Foundayo™ (orforglipron) receives FDA approval. We analyze its impact on the Southeast Asian metabolic drug market.
Learn MoreYes, our products are manufactured in facilities that meet ISO 13485 and GMP standards, which are essential for HSA Class A, B, and C registration. We provide all necessary documentation for local importers.
Thanks to our optimized logistics and proximity to major shipping hubs, we offer a turnaround time of 14-21 days for standard API and consumable orders, ensuring Singapore's supply chain remains resilient.
Our bio-fermentation and co-crystallization services allow us to tailor particle size, purity, and solubility of ingredients like Soy Protein and Walnut Peptides specifically for the Singaporean food-tech sector.
High-purity APIs and plant extracts for the pharmaceutical and nutraceutical sectors.
Partner with Jiangxi Serum Pharma for certified, high-quality medical devices and pharmaceutical products.
Contact Our Singapore Account Manager
